[ad_1]
A potential rollback of FDA moves to make the popular abortion drug mifepristone more widely available moved a step closer with the Fifth Circuit’s decision against expanded access to the medication.
US Food and Drug Administration regulations allowing mifepristone to be mailed, taken later in pregnancy, and prescribed by non-physician medical professionals were found likely to be unlawful Aug. 16 by the conservative US Court of Appeals for the Fifth Circuit. Now the legal battle is heading for the US Supreme Court, where it’s unclear whether the justices will allow the regulations to stand.
The Fifth Circuit is “trying to …
[ad_2]
Source link